Ni G H, Liang C, Zhao W D, Tian X Y, Sun H G, Gao S R, Ding L S
Department of Neurology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an 223200, China.
Zhonghua Yi Xue Za Zhi. 2017 Apr 4;97(13):1001-1005. doi: 10.3760/cma.j.issn.0376-2491.2017.13.008.
To investigate the therapeutic effects of intravenous thrombolysis, intra-artery thrombolysis, mechanical thrombectomy on patients with acute vertebrobasilar occlusion. Retrospective analysis of clinical data of patients with acute vertebrobasilar occlusion, admitted to Huai'an First People's Hospital and Bingtuan Qishi Hospital from January 2014 to January 2016, was performed. According to different vascular recanalization, these patients were divided into intravenous thrombolysis group, intra-artery thrombolysis group and mechanical thrombectomy group. Clinical outcomes were compared among the three groups such as recanalization rates( modified thrombolysis in cerebral infarction[mTICI]≥2b), changes of NIHSS scores after 24 hours(scores decreased at least 4 points or complete resolution of symptoms), symptomatic cerebral hemorrhage rate(European Cooperative Acute Stroke Study Ⅱ standard) and modified Rankin scale(mRS) score improvement 3 months after treatment. Among patients from mechanical thrombectomy group, the recanalization rate was 87.5%(28/32), 22 patients(68.8%)got good outcome according to the significant decrease of NIHSS scores, symptomatic intracranial hemorrhage occurred in 3 patient (9.4%), the rate of good prognosis(mRS≤2) at 3 months was 50.0% (16/32). In patients from intravenous thrombolysis group, the rate of recanalization was 34.8% (16/46), 12 patients(26.1%)got apparent decrease of NIHSS scores, symptomatic cerebral hemorrhage occurred in 14 patients(30.4%), the rate of good clinical outcome(mRS ≤2) at 3 months was 17.4%(8/46). Among patients from intra-arterial thrombolysis group, the recanalization rate was 53.3%(16/30), 12 patients(40.0%) got good outcome according to the significant decrease in NIHSS score, symptomatic intracranial hemorrhage occurred in 6 patients(20.0%), the rate of good prognosis(mRS≤2) at 3 months was 26.7%(8/30). The rate of complete recanalization and NIHSS score improvement at 24 hours were significantly higher in the mechanical thrombectomy group than the intravenous or intra-arterial thrombolysis group(χ(2)=21.324, <0.001; χ(2)=14.162, =0.001). The good outcome(mRS≤2) at 3 months was more frequent in the mechanical thrombectomy group than the intravenous or intra-arterial thrombolysis group (χ(2)=9.799, =0.007). The differences of symptomatic intracranial hemorrhage rate among the three treatment groups were not statistically significant(χ(2)=5.035, =0.081). As compared with the intravenous or intra-arterial thrombolysis, the mechanical thrombectomy has better efficiency and safety in the treatment of acute vertebrobasilar occlusion.
探讨静脉溶栓、动脉内溶栓、机械取栓治疗急性椎基底动脉闭塞患者的疗效。对2014年1月至2016年1月在淮安市第一人民医院和兵团第七师医院收治的急性椎基底动脉闭塞患者的临床资料进行回顾性分析。根据血管再通情况不同,将这些患者分为静脉溶栓组、动脉内溶栓组和机械取栓组。比较三组的临床结局,如再通率(改良脑梗死溶栓[mTICI]≥2b)、24小时后美国国立卫生研究院卒中量表(NIHSS)评分变化(评分至少降低4分或症状完全缓解)、症状性脑出血发生率(欧洲急性卒中协作研究Ⅱ标准)以及治疗3个月后改良Rankin量表(mRS)评分改善情况。机械取栓组患者中,再通率为87.5%(28/32),22例患者(68.8%)根据NIHSS评分显著降低获得良好结局,3例患者(9.4%)发生症状性颅内出血,3个月时良好预后(mRS≤2)率为50.0%(16/32)。静脉溶栓组患者中,再通率为34.8%(16/46),12例患者(26.1%)NIHSS评分明显降低,14例患者(30.4%)发生症状性脑出血,3个月时良好临床结局(mRS≤2)率为17.4%(8/46)。动脉内溶栓组患者中,再通率为53.3%(16/30),12例患者(40.0%)根据NIHSS评分显著降低获得良好结局,6例患者(20.0%)发生症状性颅内出血,3个月时良好预后(mRS≤2)率为26.7%(8/30)。机械取栓组24小时完全再通率和NIHSS评分改善情况显著高于静脉溶栓组或动脉内溶栓组(χ²=21.324,P<0.001;χ²=14.162,P=0.001)。机械取栓组3个月时良好结局(mRS≤2)比静脉溶栓组或动脉内溶栓组更常见(χ²=9.799,P=0.007)。三种治疗组症状性颅内出血发生率差异无统计学意义(χ²=5.035,P=0.081)。与静脉溶栓或动脉内溶栓相比,机械取栓治疗急性椎基底动脉闭塞具有更好的有效性和安全性。